Inka Health, an AI-driven drug development analytics and multimodal data services firm, was acquired for $2.1M by preclinical-stage biotechnology company Onco Innovations to enhance its ability to drive forward AI-powered precision oncology drug development.
Seller Name
Inka Health
Buyer Name
Onco Innovations
Deal Value
$2.1M
Link
Value Type
Featured Category